NCT01676584View on ClinicalTrials.gov

A Study of Single Dose RO6811135 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

RO6811135

single ascending doses sc

DRUG

placebo

single doses sc

Trial Locations (1)

45227

Cincinnati

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01676584 - A Study of Single Dose RO6811135 in Healthy Volunteers | Biotech Hunter | Biotech Hunter